---
schema_version: "secwatch.filing_event.v1"
accession: "0001001233-25-000013"
form_type: "8-K"
ticker: "SGMO"
cik: "0001001233"
company_name: "SANGAMO THERAPEUTICS, INC"
filed_at: "2025-09-30T23:59:59+00:00"
generated_at: "2026-05-17T05:12:17.599496+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Sangamo CFO Duraibabu resigns effective Oct 1, stays part-time; Jain new principal accounting officer

## Summary
- CFO Duraibabu resigns effective Oct 1, 2025; transitions to part-time principal financial officer role.
- Nikunj Jain, VP Finance & Corporate Controller since 2021, appointed principal accounting officer.
- Jain's agreement: annual base salary $347,548; target annual cash bonus 30% of base; eligible for equity awards.
- Duraibabu's part-time agreement: base salary $145,188; $160,000 retention bonus payable Jan 31, 2026.
- Duraibabu severance limited to change of control; no other severance under plan.

## SEC filing metadata
- accession: 0001001233-25-000013
- form_type: 8-K
- ticker: SGMO
- cik: 0001001233
- company_name: SANGAMO THERAPEUTICS, INC
- filed_at: 2025-09-30T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1001233/000100123325000013/0001001233-25-000013-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1001233/000100123325000013/sgmo-20250924.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001001233-25-000013
- JSON: https://secwatch.observer/filing/0001001233-25-000013.json
- Plain text: https://secwatch.observer/filing/0001001233-25-000013.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.